GT Biopharma, Inc. (GTBP): Cash & Equivalents
$6.81M
As of 2025-12-31
$4.96M
As of 2026-06-30
+6.3%
3-year compound annual growth
+5.2%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.81M | +72.4% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $3.95M | +266.2% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $1.08M | -81.0% | 2025-02-21, Balance as of period end |
| 2022-12-31 | $5.67M | -36.8% | 2024-03-26, Balance as of period end |
| 2021-12-31 | $8.97M | +69.3% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $5.30M | n/m | 2021-04-16, Balance as of period end |
| 2019-12-31 | $28.0K | -53.3% | 2021-04-16, Balance as of period end |
| 2018-12-31 | $60.0K | -89.6% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $576.0K | n/m | 2019-03-29, Balance as of period end |
| 2016-12-31 | $19.0K | -59.6% | 2018-03-01, Balance as of period end |
| 2015-12-31 | $47.0K | -94.5% | 2018-02-28, Balance as of period end |
| 2014-12-31 | $855.0K | n/m | 2018-02-28, Balance as of period end |
| 2013-12-31 | $43.0K | -65.0% | 2015-03-31, Balance as of period end |
| 2012-12-31 | $123.0K | +33.7% | 2015-01-08, Balance as of period end |
| 2011-12-31 | $92.0K | +70.4% | 2014-11-18, Balance as of period end |
| 2010-12-31 | $54.0K | n/a | 2012-04-16, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | 2025-12-31 | $6.81M | +72.4% |
| Revium Rx. (RVRC) | 2025-12-31 | $1.68M | -48.7% |
| Dermata Therapeutics, Inc. (DRMA) | 2025-12-31 | $7.52M | +137.9% |
| Processa Pharmaceuticals, Inc. (PCSA) | 2025-12-31 | $5.54M | +364.8% |
| Palatin Technologies Inc (PTN) | 2026-06-30 | $7.49M | +192.2% |
| CNS Pharmaceuticals, Inc. (CNSP) | 2025-12-31 | $7.20M | +11.4% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| Rocket One Inc. (RKTO) | 2025-12-31 | $6.25M | -11.2% |
| GRI Bio, Inc. (GRI) | 2025-12-31 | $8.23M | +63.7% |
Compare GTBP, RVRC, DRMA, PCSA side by side · Screen every company in Pharmaceutical Preparations ↗